Central Diabetes Insipidus

DBCOND0051168Digestive System DiseasesEndocrine System Diseases

Central Diabetes Insipidus is the indication for 1 drug in DrugBank. It is covered by 3 curated, structured indications.

Also known as
Diabetes Insipidus, Neurogenic · Diabetes Insipidus, Neurohypophyseal · Diabetes Insipidus Cranial Type
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0328375ICD-10E23.2SNOMED CT1296758008MedDRA10012599UMLSC0011848

What you can answer from here — as of October 23, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
18Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Central Diabetes Insipidus share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In